Larin 1/20 Kit
Product Images NDC 16714-408

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Larin 1/20 (NDC 16714-408). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Image 01)

Chemical structure diagram showing the molecular structures of Norethindrone Acetate and Ethinyl Estradiol, the active ingredients in Larin 1/20. Both steroid-based hormones are depicted with labeled chemical bonds and molecular components.*

FDA Label Image

2 (Image 02)

A table titled 'Lowest Expected and Typical Failure Rates During the First Year of Continuous Use of a Method,' showing percentages of women experiencing unintended pregnancies for various contraceptive methods. Methods include oral contraceptives, diaphragms, spermicides, vaginal sponge, implants, injections, IUDs, condoms, cervical caps, withdrawal, and sterilization, with columns for lowest expected and typical failure rates.*

FDA Label Image

3 (Image 03)

A drug warning text panel highlighting the increased risk of serious cardiovascular side effects from oral contraceptive use in cigarette smokers, especially women over 35 years of age and those who smoke heavily (15 or more cigarettes per day). It advises women using oral contraceptives to avoid smoking.*

FDA Label Image

4 (Image 04)

A bar chart titled 'Table II Circulatory Disease Mortality Rates per 100,000 Woman Years by Age, Smoking Status and Oral Contraceptive Use.' The vertical axis represents mortality rate (number of deaths per 100,000 women), ranging from 0 to 250. The horizontal axis shows age groups (15-24, 25-34, 35-44, and 45 and older). Bars distinguish between ever-users and controls, separated by smoking status (non-smokers and smokers) using different shading patterns.*

FDA Label Image

5 (Image 05)

A data table titled 'Annual Number of Birth-Related or Method-Related Deaths Associated with Control of Fertility per 100,000 Nonsterile Women by Fertility Control Method According to Age' showing death rates for different fertility control methods among women aged 15-44. Methods include no fertility control, oral contraceptives (non-smoker and smoker), IUD, condom, diaphragm/spermicide, and periodic abstinence, with numeric death rates listed by five age groups.*

FDA Label Image

6 (Image 06)

A warning text panel stating that cigarette smoking increases the risk of serious cardiovascular side effects from oral contraceptive use, with higher risks for women over 35 years of age and heavy smokers (15 or more cigarettes per day). It advises women who use oral contraceptives not to smoke.*

FDA Label Image

7 (Image 07)

Instructional diagram showing how to use the day label strip on the Larin 1/20 oral contraceptive pill kit by Northstar Rx LLC. The image guides users to place the day label starting with the first day of their period if not Sunday, indicating pill directions from left to right each week.*

FDA Label Image

8 (Image 08)

A warning text panel advising that cigarette smoking increases the risk of serious cardiovascular side effects from oral contraceptive use. It notes that this risk grows with age and heavy smoking (15 or more cigarettes per day), and is especially significant in women over 35 years of age. Women using oral contraceptives are strongly advised not to smoke.*

FDA Label Image

9 (Image 09)

A data table presenting the annual number of birth-related or method-related deaths per 100,000 nonsterile women by fertility control method and age group. The table lists various methods including no fertility control, oral contraceptives for smokers and non-smokers, IUD, condom, diaphragm/spermicide, and periodic abstinence, with death rates broken down by age ranges from 15-19 to 40-44 years.*

FDA Label Image

10 (Image 10)

An instructional diagram showing how to use the day label strip on the Larin 1/20 kit. A hand is placing a Monday label strip over the original Sunday label on the medication pack. Arrows guide users to start with the proper strip based on their period start day and to take pills from left to right each week.*

FDA Label Image

11 (Image 11)

FDA Label Image

12 (Image 12)

Larin 1/20 kit containing Norethindrone Acetate and Ethinyl Estradiol tablets, USP, from Northstar Rx LLC. The label shows 3 blister cards of 21 tablets each. The package includes text about tablet strength, dosage form, storage instructions, a barcode, lot and expiration details, and a small blue flower graphic.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.